Efficacy of Risperidone Augmentation with Ondansetron in the Treatment of Negative and Depressive Symptoms in Schizophrenia: A Randomized Clinical Trial

Efficacy of Risperidone Augmentation with Ondansetron in the Treatment of Negative and Depressive Symptoms in Schizophrenia: A Randomized Clinical Trial

Background: Given the potential role of the 5-hydroxytryptamine-3 receptor in the pathogenesis of schizophrenia, this study was performed to determine whether ondansetron plus risperidone could reduce the negative and depressive symptoms in patients with treatment-resistant schizophrenia. Methods:...

Full description

Bibliographic Details
Main Authors: Roya Samadi, Reza Daneshmand, Shervin Assari, Ali Akhoundpour Manteghi
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2017-01-01
Series:Iranian Journal of Medical Sciences
Subjects:
Schizophrenia
Risperidone
Ondansetron
Depression
Negative symptoms
Online Access:http://ijms.sums.ac.ir/index.php/IJMS/article/view/2231

Internet

http://ijms.sums.ac.ir/index.php/IJMS/article/view/2231

Similar Items